In addition, BRAFP1 genomic locus was found amplified in the vast majority of cancer types featured in TCGA, including DLBCL, where, as expected by ceRNA partners, BRAFP1 and BRAF expression levels show a positive correlation. This evidence concerns the gene BRAF and diffuse large B-cell lymphoma.